DHAWAN D. and SHARMA S.: Abdominal Obesity,
Adipokines and Non-communicable Diseases. The Journal
of steroid biochemistry and molecular biology, 203:
105737, 2020.
2- Papaetis G.S., Papakyriakou P. and Panagiotou T.N.:
Central obesity, type 2 diabetes and insulin: Exploring a
pathway full of thorns. Archives of medical science: AMS,
11 (3): 463-482, 2015.
3- SWARUP S., GOYAL A., GRIGOROVA Y. and ZELTSER
R.: Metabolic Syndrome. In StatPearls. StatPearls
Publishing, 2021.
4- Deacon C.F.: Physiology and Pharmacology of DPP-4 in
Glucose Homeostasis and the Treatment of Type 2 Diabetes.
Frontiers in Endocrinology, 10: 80, 2019.
5- Verkouter I., Noordam R., le Cessie S., van Dam R.M.,
Lamb H.J., Rosendaal F.R., van Heemst D. and de Mutsert
R.: The Association between Adult Weight Gain and
Insulin Resistance at Middle Age: Mediation by Visceral
Fat and Liver Fat. Journal of Clinical Medicine, 8 (10):
1559, 2019.
6- Bjornstad P. and Eckel R.H.: Pathogenesis of Lipid Disorders
in Insulin Resistance: A Brief Review. Current
Diabetes Reports, 18 (12): 127, 2018.
7- Arabpour-Dahoue M., Mohammadzadeh E., Avan A.,
Nezafati P., Nasrfard S. and Ghazizadeh H.: Leptin level
decreases after treatment with the combination of Radiofrequency
and Ultrasound cavitation in response to the
reduction in adiposity. Diabetes & metabolic syndrome,
13 (2): 1137-1140, 2019.
8- Pruksapong C., Chamnanchanunt S., Thanachartwet V.,
Desakorn V., Nakawiro D., Sahassananda D. and Rojnuckarin
P.: Association of Body Dysmorphic Disorder with
Leptin Levels in Patients with Normal Weight Undergoing
Liposuction: A Matched Case Study. Plastic and reconstructive
surgery. Global Open, 7 (10): e2482, 2019.
9- De Lucia Rolfe E., Ong K.K., Sleigh A., Dunger D.B.
and Norris S.A.: Abdominal fat depots associated with
insulin resistance and metabolic syndrome risk factors in
black African young adults. BMC Public Health, 15: 1013,
2015.
10- Gibas-Dorna M., Turkowski P., Bernatek M., Mikrut K.,
Kupsz J. and Pia¸tek J.: Liposuction-induced metabolic
alterations the effect on insulin sensitivity, adiponectin,
leptin and resistin. Journal of Medical Science, 84 (4):
249-256, 2015.
11- Kim S.H., Chung J.H., Song S.W., Jung W.S., Lee Y.A.
and Kim H.N.: Relationship between deep subcutaneous
abdominal adipose tissue and metabolic syndrome: A case
control study. Diabetology & Metabolic Syndrome, 12
(8): 10, 2016.
12- Ghafoor L., Entezari V., Fallah A. and Hajian A.: Lipoabdominoplasty
and the leptin hormone. Annals of Medicine
and Surgery, 68: 102633, 2021.
13- Freeman A.M. and Pennings N.: Insulin Resistance. In
StatPearls. StatPearls Publishing, 2021.
14- American Diabetes Association; 2. Classification and
Diagnosis of Diabetes (2021): Standards of Medical Care
in Diabetes-2021. Diabetes Care 1 January, 44 (Supplement
1): S15-S33, 2021.
15- Casadei K. and Kiel J.: Anthropometric Measurement. In
Stat Pearls. Stat Pearls Publishing, 2021.
16- Gibas-Dorna M., Szulin´ska M., Turkowski P., Kupsz J.,
Sowin´ska A., Mikrut K., Bernatek M. and Piatek J.: The
Effect of VASER Abdominal Liposuction on Metabolic
Profile in Overweight Males. American Journal of Men's
Health, 11 (2): 284-293, 2017.
17- Ramos-Gallardo G., Pérez Verdin A., Fuentes M., Godínez
Gutiérrez S., Ambriz-Plascencia A.R., González-García
I., Gómez-Fonseca S.M., Madrigal R., González-Reynoso
L.I., Figueroa S., Toscano Igartua X. and Jiménez Gutierrez
D.F.: Effect of abdominoplasty in the lipid profile of
patients with dyslipidemia. Plastic surgery international,
861348, 2013.